We developed inhouse an Proprietary Metagenomic Artificial intelligent (AI) Platform that enables discovery and validation of novel biological molecules (e.g enzymes, proteins, peptides etc) from African terrestrial and marine microbial hotspots.
Learn More about BioDiscovery AI
We have developed the solution for detecting infectious diseases using novel Bst DNA polymerase enzyme. The enzyme is also formulated with a Reverse transcriptase enzyme to make RT-LAMP Assay. Both Mastermixes (Readymixes) are sold as Research Use Only (RUO) products. We offer support to IVD developers who source this technology from us.
We have developed the solution for detecting infectious diseases using Real-Time or quantitative PCR (formulation includes wild-type, mutant, Hot-Start Taq DNA polymerases and specialized high fidelity/high performance DNA polymerases). The Mastermix (Readymix) is sold as Research Use Only (RUO) product. We offer support to IVD developers who source this technology from us.
We have developed the solution for detecting infectious diseases using Reverse transcriptase – quantitative Polymerase Chain Reaction (RT-qPCR) . There are different proprietary formulations that are used to detect various infectious pathogens – including SARS-Cov-2 . This technology was recently used to develop Capebio SARS-Cov-2 IVD and is being exploited to develop other IVDs. The Mastermixes (Readymixes) are sold as Research Use Only (RUO) products. We offer support to IVD developers who source this technology from us.